Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

UC Davis research highlights need for better guidance for primary care providers

Short questionnaires used to identify patients at risk for depression are linked with antidepressant medications being prescribed when they may not be needed, according to new research from UC Davis Health System published in the September-October issue of the Journal of the American Board of Family Medicine.

30 Sep 2014

ED more prevalent than previously thought

Specialists in treatment of erectile dysfunction recognize that ED is more prevalent than previously recognized.

29 Sep 2014

American men have worse access to reproductive and sexual health care, shows research

Compared with women, American men have worse access to reproductive and sexual health care, research shows, a disparity fueled in part by the lack of standard clinical guidelines on the types and timing of exams, tests and treatments that should be offered to all men of reproductive age.

10 Sep 2014

Men who are not well educated about prostate cancer face decisional conflict, finds UCLA study

They say knowledge is power, and a new UCLA study has shown this is definitely the case when it comes to men making the best decisions about how to treat their prostate cancer.

28 Aug 2014

Loyola's Sexual Wellness Clinic to help break down the stigma associated with sexual dysfunction

Sexual dysfunction among couples is common, yet it often goes untreated, according to specialists at Loyola University Health System's Sexual Wellness Clinic.

31 Jul 2014

Researchers identify two classes of anti-depressants that reduce symptoms of depression

Depression is common in cancer, up to half of all patients facing the disease experience depressive symptoms, ranging from mild to severe. When depression co-exists with cancer, patients may be at an increased risk of death from cancer and from suicide.

28 Jun 2014

Researchers perform systematic review to identify best treatments for cancer-related depression

27 Jun 2014

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Trimel Pharmaceuticals Corporation announced today that the United States Food and Drug Administration (FDA) has approved Natesto (testosterone), formerly CompleoTRT, the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

29 May 2014

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina™, a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).

28 May 2014

Study on premature ejaculation could lead to improved diagnosis and treatment for affected men

There are many misconceptions and unknowns about premature ejaculation in the medical community and the general population. Two papers, both being published simultaneously in Sexual Medicine and the Journal of Sexual Medicine, provide much-needed answers that could lead to improved diagnosis and treatment for affected men.

22 May 2014

Reversing erectile dysfunction possible with lifestyle changes

Men suffering from sexual dysfunction can be successful at reversing their problem, by focusing on lifestyle factors and not just relying on medication, according to research at the University of Adelaide.

29 Mar 2014

Study: Sexual dysfunction common with lung cancer

Many lung cancer patients suffer difficulties with sexual expression and intimacy, yet for too long the topic has been ignored by doctors and researchers, experts have said at the 4th European Lung Cancer Conference (ELCC).

28 Mar 2014

Residual symptoms linked to poor functioning in euthymic bipolar disorder

Residual symptoms are associated with functional impairment in euthymic individuals with bipolar disorder, a large observational study has shown.

26 Feb 2014

NIH-funded session in Bethesda to heighten awareness of underactive bladder

Underactive bladder, estimated to affect more than 20 percent of the elderly population, is an unrecognized disease that has a major influence on the health and independence of seniors.

20 Feb 2014

Nonsurgical treatment improves symptoms in women with pelvic floor dysfunction

One in three women suffer from pelvic floor dysfunction, a range of symptoms which include bladder and bowel problems as well as pelvic pain, according to the American Urogynecologic Society. Now, University of Missouri researchers have demonstrated that a comprehensive, nonsurgical treatment significantly improves symptoms in women with PFD.

10 Jan 2014

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.

30 Dec 2013

Can-Fite reports positive results from CF101 Phase IIb study for rheumatoid arthritis

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced results from a 12-week, placebo-controlled Phase IIb study involving 79 patients with active rheumatoid arthritis ("RA") for its proprietary drug CF101, an A3 adenosine receptor ("A3AR") agonist.

23 Dec 2013

Endocrine Society issues scientific statement on health consequences of performance-enhancing drugs

A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.

18 Dec 2013

AP, Kaiser Permanente initiate clinical trial to evaluate the efficacy of Promescent lidocaine spray

Absorption Pharmaceuticals LLC in collaboration with Kaiser Permanente announced today the initiation of a clinical trial to evaluate the efficacy of Promescent lidocaine spray for men with premature ejaculation. This Phase III, double blind, placebo-controlled, randomized study will measure the intravaginal ejaculatory latency time for subjects aged 18 and older.

11 Dec 2013

Exercise at the right time improves sexual functioning in women who take antidepressants

New psychology research, which could have important public health implications for alleviating some side effects of antidepressants, shows that engaging in exercise at the right time significantly improves sexual functioning in women who are taking the antidepressants.

11 Dec 2013

Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

UC Davis research highlights need for better guidance for primary care providers

ED more prevalent than previously thought

American men have worse access to reproductive and sexual health care, shows research

Men who are not well educated about prostate cancer face decisional conflict, finds UCLA study

Loyola's Sexual Wellness Clinic to help break down the stigma associated with sexual dysfunction

Researchers identify two classes of anti-depressants that reduce symptoms of depression

Researchers perform systematic review to identify best treatments for cancer-related depression

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Study on premature ejaculation could lead to improved diagnosis and treatment for affected men

Reversing erectile dysfunction possible with lifestyle changes

Study: Sexual dysfunction common with lung cancer

Residual symptoms linked to poor functioning in euthymic bipolar disorder

NIH-funded session in Bethesda to heighten awareness of underactive bladder

Nonsurgical treatment improves symptoms in women with pelvic floor dysfunction

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

Can-Fite reports positive results from CF101 Phase IIb study for rheumatoid arthritis

Endocrine Society issues scientific statement on health consequences of performance-enhancing drugs

AP, Kaiser Permanente initiate clinical trial to evaluate the efficacy of Promescent lidocaine spray

Exercise at the right time improves sexual functioning in women who take antidepressants

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in